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ABSTRACT
Background
Cancer follow-up places a significant burden on hospital
outpatient clinics. There are increasing calls to develop
alternative models of provision.
Aim
To undertake a systematic review of qualitative studies
examining patients’ and healthcare professionals’ views
about cancer follow-up.
Design of study
Systematic review.
Setting
Primary and secondary care.
Method
Comprehensive literature searches included: 19
electronic databases, online trial registries, conference
proceedings, and bibliographies of included studies.
Eligible studies included qualitative studies examining
patients’ and healthcare professionals’ views of cancer
follow-up. Studies of patients with any type of cancer,
considered free of active disease, or no longer receiving
active treatment were included. Findings were
synthesised using thematic analysis.
Results
Nineteen studies were included; seven were linked to
randomised controlled trials. Eight studies examined the
views of healthcare professionals (four of which included
GPs) and 16 examined the views of patients. Twelve
descriptive themes were identified, from which 12
perceived implications for practice were derived. Most
themes related to conventional follow-up in secondary
care. Some views concerning other models of care were
based on participants’ ideas, rather than experiences.
Conclusion
Patients’ main concern is recurrent disease, and they
find regular follow-up, expertise of specialists, and quick
access to tests reassuring. Information regarding the
effectiveness of follow-up is not given to patients who
also have unmet information needs, which would help
them to cope and be more involved. Continuity of care,
unhurried consultations, and psychosocial support are
important, but sometimes lacking in secondary care.
GPs are thought to be unwilling and to have insufficient
time and expertise to conduct follow-up.
Keywords
long-term care; neoplasms; oncologic nursing;
outpatients; primary health care; systematic review.
INTRODUCTION
Conventional hospital-based follow-up of cancer
patients places a significant burden on hospital
outpatient clinics, and is of debatable value for many
cancers in terms of early diagnosis of recurrence and
improved survival.1–6 Consequently, there is continued
interest in the provision of follow-up or ongoing
management in different and innovative ways. Models
typically include primary care follow-up,7 nurse-led
follow-up,8 telephone-based follow-up, and patient-
initiated follow-up (or combinations of these).
As the number of cancer survivors increases, the
focus of follow-up is shifting towards the
management of a chronic condition. In the UK there is
growing government pressure for the NHS to
encourage patients with chronic conditions to take
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more responsibility for their own care,9 and there is
some evidence from other chronic conditions, such
as diabetes, that empowerment could lead to better
patient outcomes.10,11 For cancer survivorship,
management as a chronic condition would need a
comprehensive care package with the input of both
primary and secondary care.
The views of patients and healthcare
professionals are important in informing policy,
especially in the absence of conclusive evidence
regarding the comparative value of cancer follow-up
models.12 Therefore, a systematic review of
qualitative studies was undertaken to explore
patients’ and healthcare professionals’ views and
preferences with regard to cancer follow-up. This
was part of a broader systematic review that also
evaluated the effectiveness and cost-effectiveness
of primary versus secondary care follow-up of
cancer patients, the findings of which are presented
separately.13 The broader review also looked at
nurse-led follow-up and the findings of which are
reported elsewhere.14
METHOD
The following databases were searched (from
inception to February 2007) using strategies
designed specifically for each database: MEDLINE,
MEDLINE in process, EMBASE, CINAHL,
PsychINFO, AMED, BIOSIS, Index to Scientific and
Technical proceedings, Science Citation Index,
Social Science Citation Index, Cochrane Central
Register of Controlled Trials, Database of Abstracts
of Reviews of Effects, Cochrane Database of
Systematic Reviews, Health Technology Assessment
database, NHS Economic Evaluation database,
System for Information on Grey Literature, British
Nursing Index, Health Management Information
Consortium, National Research Register, and other
trial registries (n = 7) available via the internet. No
language restrictions were used; full details of the
search strategy are available on request and
described elsewhere (R Lewis et al, unpublished
data, 2007). (For more information see Appendix 1,
Lewis et al13). Additional references were identified
through reviewing the bibliographies of 16 retrieved
systematic reviews and 42 included studies, and
hand searching five conference proceedings.
The search included qualitative studies that used
interviews, focus groups, or open-ended questions
to elicit patients’ or healthcare professionals’ views
or preferences regarding cancer follow-up
(irrespective of provider). Surveys using only closed
questions were excluded. The population of interest
included patients of any age who had received
treatment for any type and stage of cancer. Only
studies that examined follow-up for the following
purposes were included: to identify recurrent
tumours or new primary disease; to provide support
for complications or delayed side-effects of
treatments; or to identify patients requiring additional
help or treatment (for example, for functional or
psychological problems). Studies of patients still
receiving hospital-based treatment (for example;
radiotherapy), rehabilitation, or specialist palliative
care were excluded. However, patients in follow-up
who were receiving long-term therapy, such as
hormonal treatment for breast or prostate cancer,
(but free of active disease) were included.
Review of people’s views was carried out using the
method reported by Thomas and Harnden,15 and
Harden et al,16 which followed guidelines for thematic
analysis of textual data. Two reviewers independently
assessed the results of the literature searches and
the relevance of retrieved studies. Data pertaining to
each study’s methodology and context were
extracted by one reviewer and checked by a second
independent reviewer, while the data were extracted
by two independent reviewers. Disagreements were
resolved by discussion.
Quality assessment was conducted by two
independent reviewers based on the Critical
Appraisal Skills Programme17 and a checklist
developed by Greenhalgh and Taylor.18
Disagreements were resolved by discussion. Studies
were not excluded from the analysis based on
quality.
Key points identified in the results section of the
primary studies represented the basic units of the
review analysis. Where possible, these were
extracted verbatim to avoid misinterpretation. Where
results were presented in more lengthy, unfocused
prose, the key points were paraphrased succinctly,
adhering as closely as possible to the language and
meaning of the original. Data reported in the
discussion were disregarded, as were direct quotes.
The resulting list of key points was then coded by
two independent reviewers using QSR N6 software
(QSR International), with most points being allocated
multiple codes. The final coding was agreed by three
How this fits in
Routine hospital follow-up does not lead to early diagnosis of recurrence and
improved survival in most cancer sites. However, patients want follow-up to
allay fears of recurrence and provide psychosocial support. There is a need for
improved information and education for cancer patients to enable them to make
an informed choice about follow-up and to promote their autonomy. In terms of
organisation, improved communication between primary and secondary care is
essential. Alternative models of follow-up should involve the whole cancer team,
including primary care, and include training, support, and rapid access to
investigations.
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reviewers. The codes were organised into a
hierarchical tree structure and overarching
descriptive themes identified using group
discussion, in keeping with the methodology
reported by Thomas et al.15 The study then moved
onto the next stage of the analysis that went beyond
the findings of the original studies: from peoples’
views captured by the descriptive themes, the
reviewers inferred positive or negative characteristics
for different aspects of follow-up.
The implication of these findings for policy and
practice was then considered, in light of the broader
aims of the review, the findings of the effectiveness
section of the review, the increasing push to
discontinue routine hospital follow-up, and the
development of alternative models of follow-up. This
was initially developed by two independent
reviewers and then checked and commented on by
two further independent reviewers. The final list of
‘ideal world’ implications was discussed and agreed
by three reviewers, while re-examining the data
captured by the descriptive themes.
RESULTS
The electronic searches identified 43 861 references
of which 232 papers were retrieved in full. Thirty-one
additional studies were identified by hand searching
(see Figure 1, Lewis et al13).
Nineteen relevant qualitative studies published in
full were identified.1,12,19–35 Two further studies that
were only published as conference abstracts were
identified, and are not discussed further due to the
limited information presented.36,37 Two projects on the
National Research Register were identified, for which
no results were available.38,39
Eight studies were linked to randomised controlled
trials (RCTs) evaluating different modes of follow-up
(included in the effectiveness section of this
systematic review).19,21,22,24,27–29,31 Two were related to
the same trial and examined the intervention and
control groups separately.28,29
A summary of included studies is presented in
Table 1. Ten studies evaluated breast cancer follow-
up,1,19,20,22,24,26,28–30,32 four multiple cancer sites,21,27,34,35 two
colorectal,12,33 two lung,25,31 and one study evaluated
gynaecological cancers.23 Eight studies examined
the views of healthcare professionals,1,21,25–27,30,31,35 four
of which examined the views of GPs.21,25–27 Sixteen
studies included patients;1,12,19–26,28–30,32–34 15 collected
patients’ views on routine hospital follow-
up;1,12,19–26,29,30,32–34 three included patients who
experienced nurse-led follow-up,24,28,30 and two
included patients who received GP follow-up.12,21 The
number of included patients ranged from six20 to
11319 (median = 24), and healthcare professionals
from two31 to 1201 (median = 7). The number of
included participants was not stated for one study.26
Most studies were European (12 undertaken in the
UK,1,12,19,20,22–26,30–32 two in Norway,21,27 and two in
Sweden28,29). Two were carried out in Canada33,35 and
one in China (Hong Kong).34 The time period over
which the data were collected was not stated for
most studies; where it was reported (six studies)
most of these studies were undertaken within the
time period 2000–2005,12,19,21,25,30 with one study
collecting data between 1992 and 1993.35 Various
data-collection methods were used, with some
studies using more than one method, which included
direct observation of consultation,1 focus groups22,26,34
in-depth interviews,12,20,25 semi-structured
interviews,1,19,21,23,27–33,35 structured interviews,24 and
survey questionnaires (with open-ended
questions).1,21,25
Study quality is presented in Table 2. Most studies
were poorly reported and the quality of the methods
could not be assessed. In general, the sample
strategy and size, and reasons why some
participants declined to participate were poorly
described or not reported. Summary characteristics
of included participants were missing in many
studies. The researchers’ perspectives could have
influenced responses in some studies (for example,
nurse investigating nurse-led follow-up), and was
often not reported. Few studies reported testing the
credibility of their findings; it was not clear if all the
data had been taken into account and whether
negative or discrepant findings were addressed.
When reporting conclusions, few studies explored
alternative explanations or discussed the limitations
of their findings.
Findings of included studies
Twelve descriptive themes were identified; these
were interpreted to develop a list of 12
recommendations for policy and practice (Box 1).
Fear of recurrence was the main reason for patients’
anxiety and need for reassurance. Patients feared
recurrence, especially during the early phase after
completing treatment,1,22,23,32,34 and wanted regular
surveillance.22 Healthcare professionals’ reluctance
to talk about ‘cure’, and patients’ understanding of
‘remission’ as a stage in the disease rather than a
period of good health, helped to maintain the focus
on detection of recurrence.23,26
Conventional follow-up, although intended to allay
anxiety, exacerbated patients’ need for reassurance.
A system of regular check-ups with tests and
examinations provided only temporary reassurance;
and by the time of the patients’ next appointment
their anxiety had returned.1,12,20,22,23,25,26,29,32 Healthcare
RA Lewis, RD Neal, M Hendry, et al
British Journal of General Practice, July 2009 e251
Systematic Reviews
P
ar
to
fR
C
T?
Ty
pe
of
C
an
ce
r
S
tu
dy
ty
pe
S
tu
dy
an
d
co
un
tr
y
(tr
ia
lr
ef
er
en
ce
)
P
ar
tic
ip
an
ts
fo
llo
w
-u
p
si
te
(th
eo
re
tic
al
pe
rs
pe
ct
iv
e)
C
om
m
en
ts
A
de
w
uy
i-D
al
to
n,
Y
E
S
—
C
on
tr
ol
P
at
ie
nt
s
(n
=
11
3)
H
os
pi
ta
l
B
re
as
t
S
em
i-s
tr
uc
tu
re
d
in
te
rv
ie
w
s
C
at
eg
or
ie
s
an
d
th
em
es
no
td
er
iv
ed
fro
m
th
e
da
ta
—
19
98
19
gr
ou
p
on
ly
(N
ot
st
at
ed
)
th
em
es
w
er
e
de
ci
de
d
in
ad
va
nc
e
an
d
da
ta
w
er
e
se
le
ct
ed
U
K
(h
os
pi
ta
lv
s
G
P
)51
to
fit
th
e
th
em
es
A
lle
n,
20
04
20
N
O
P
at
ie
nt
s
(n
=
6)
H
os
pi
ta
l
B
re
as
t
In
-d
ep
th
in
te
rv
ie
w
s
A
ll
pa
tie
nt
s
tr
ea
te
d
by
sa
m
e
su
rg
eo
n
an
d
on
co
lo
gi
st
;n
ot
U
K
(P
he
no
m
en
og
ra
ph
y)
st
at
ed
ho
w
th
ey
w
er
e
se
le
ct
ed
/r
ec
ru
ite
d.
R
es
ea
rc
h
co
nd
uc
te
d
by
a
M
cM
ill
an
br
ea
st
ca
nc
er
nu
rs
e
A
nv
ik
,2
00
62
1
Y
E
S
—
In
te
rv
en
tio
n
P
at
ie
nt
s
(n
=
91
)
In
te
gr
at
ed
M
ul
tip
le
G
P
s:
se
m
i-s
tr
uc
tu
re
d
in
te
rv
ie
w
s
P
at
ie
nt
s’
vi
ew
s
ba
se
d
on
fre
e
te
xt
co
m
m
en
ts
fro
m
N
or
w
ay
+
co
nt
ro
lg
ro
up
s
G
P
s
(n
=
23
)
ho
sp
ita
l
si
te
an
d
fo
cu
s
gr
ou
ps
(n
=
6;
17
qu
es
tio
nn
ai
re
s
(c
on
tr
ol
gr
ou
p)
or
co
m
m
en
ts
re
co
rd
ed
by
G
P
s
(fo
rm
al
co
ns
ul
ta
tio
n
an
d
G
P
pa
rt
ic
ip
an
ts
in
ea
ch
gr
ou
p)
.
in
re
sp
on
se
to
op
en
-e
nd
ed
qu
es
tio
ns
us
ed
du
rin
g
w
ith
G
P
pl
us
P
at
ie
nt
s:
su
rv
ey
qu
es
tio
nn
ai
re
s
co
ns
ul
ta
tio
n
(in
te
rv
en
tio
n
gr
ou
p)
ho
sp
ita
lf
ol
lo
w
-u
p
vs
—
op
en
en
de
d
qu
es
tio
ns
—
or
co
nv
en
tio
na
lh
os
pi
ta
l
sa
m
e
qu
es
tio
ns
as
ke
d
by
G
P
s,
fo
llo
w
-u
p)
52
G
P
s
m
ad
e
no
te
s
of
an
sw
er
s
(P
he
no
m
en
og
ra
ph
y)
B
ea
ve
r,
20
05
1
N
O
C
lin
ic
al
co
ns
ul
ta
tio
n
(n
=
10
6)
;
H
os
pi
ta
l
B
re
as
t
D
ire
ct
ob
se
rv
at
io
n
of
co
ns
ul
ta
tio
n;
W
el
l-c
on
du
ct
ed
an
d
cl
ea
rly
re
po
rt
ed
st
ud
y
U
K
H
C
P
s
(n
=
14
);
pa
tie
nt
s
(n
=
92
);
au
di
o-
re
co
rd
ed
.P
at
ie
nt
s:
su
rv
ey
H
C
P
s
=
co
ns
ul
ta
nt
su
rg
eo
n,
qu
es
tio
nn
ai
re
s;
op
en
+
cl
os
ed
co
ns
ul
ta
nt
cl
in
ic
al
on
co
lo
gi
st
,
qu
es
tio
ns
.H
C
P
s:
S
em
i-s
tr
uc
tu
re
d
sp
ec
ia
lis
tr
eg
is
tr
ar
,s
pe
ci
al
is
tb
re
as
t
in
te
rv
ie
w
s.
(E
th
no
gr
ap
hi
c
ap
pr
oa
ch
ca
re
nu
rs
e,
cl
in
ic
st
af
fn
ur
se
s,
–
no
n-
pa
rt
ic
ip
an
to
bs
er
va
tio
n,
an
d
cl
in
ic
m
an
ag
er
m
od
ifi
ed
gr
ou
nd
ed
th
eo
ry
)
B
ra
db
ur
n,
19
95
22
N
O
—
(U
se
d
to
P
at
ie
nt
s
(n
=
29
)
H
os
pi
ta
l
B
re
as
t
3
fo
cu
s
gr
ou
ps
of
P
ar
tic
ip
an
ts
pr
im
ar
ily
re
cr
ui
te
d
vi
a
lo
ca
lc
an
ce
r
su
pp
or
t
U
K
in
fo
rm
R
C
T
8–
12
pa
rt
ic
ip
an
ts
gr
ou
ps
.P
oo
rly
re
po
rt
ed
st
ud
y
pr
ot
oc
ol
(N
ot
st
at
ed
)
de
ve
lo
pm
en
t,
ho
sp
ita
lv
s
G
P
)51
B
ra
dl
ey
,1
99
92
3
N
O
P
at
ie
nt
s
(n
=
12
)
H
os
pi
ta
l
G
yn
ae
S
em
i-s
tr
uc
tu
re
d
in
te
rv
ie
w
s
P
oo
rly
re
po
rt
ed
st
ud
y.
O
ne
re
se
ar
ch
er
co
nd
uc
te
d
al
lt
he
U
K
(G
ro
un
de
d
th
eo
ry
)
in
te
rv
ie
w
s;
no
ts
ta
te
d
if
>1
re
se
ar
ch
er
in
vo
lv
ed
in
an
al
ys
is
,
an
d
no
qu
al
ity
co
nt
ro
lm
ea
su
re
s
de
sc
rib
ed
.A
na
ly
se
s,
th
em
es
,
an
d
ca
te
go
rie
s
no
tf
ul
ly
ex
pl
ai
ne
d.
Q
uo
ta
tio
ns
w
er
e
an
on
ym
ou
s
—
no
m
ea
ns
of
te
lli
ng
w
he
th
er
th
ey
w
er
e
fro
m
di
ffe
re
nt
pa
tie
nt
s
or
no
t
B
ro
w
n,
20
02
24
U
K
Y
E
S
—
P
at
ie
nt
s
(n
=
61
)
H
os
pi
ta
la
nd
B
re
as
t
S
tr
uc
tu
re
d
in
te
rv
ie
w
s
(fa
ce
-t
o
In
te
rv
ie
w
s
co
nd
uc
te
d
by
a
re
se
ar
ch
nu
rs
e;
st
ru
ct
ur
ed
In
te
rv
en
tio
n
+
P
I-
N
ur
se
fa
ce
or
te
le
ph
on
e)
in
te
rv
ie
w
sc
he
du
le
in
cl
ud
ed
6
ite
m
s
th
at
w
er
e
no
tr
ep
or
te
d.
co
nt
ro
lg
ro
up
(te
le
ph
on
e)
(N
ot
st
at
ed
)
O
nl
y
ve
ry
br
ie
fd
et
ai
ls
of
an
al
ys
is
gi
ve
n;
nu
m
be
r
of
re
se
ar
ch
er
s
(N
ur
se
vs
in
vo
lv
ed
no
ts
ta
te
d.
Q
ua
lit
at
iv
e
da
ta
an
al
ys
ed
in
a
ho
sp
ita
l)2
4
pr
ed
om
in
an
tly
qu
an
tit
at
iv
e
m
an
ne
r
us
in
g
st
at
is
tic
al
te
st
s
to
co
m
pa
re
gr
ou
ps
.N
o
m
et
ho
d
re
po
rt
ed
to
en
su
re
ac
cu
ra
cy
of
gr
ad
in
g
da
ta
in
to
bi
na
ry
ou
tc
om
es
...
co
nt
in
ue
d
Ta
b
le
1.
S
um
m
ar
y
o
f
ty
p
e
o
f
p
ar
ti
ci
p
an
ts
in
cl
ud
ed
in
q
ua
lit
at
iv
e
st
ud
y.
British Journal of General Practice, July 2009e252
RA Lewis, RD Neal, M Hendry, et al
P
ar
to
fR
C
T?
Ty
pe
of
C
an
ce
r
S
tu
dy
ty
pe
S
tu
dy
an
d
co
un
tr
y
(tr
ia
lr
ef
er
en
ce
)
P
ar
tic
ip
an
ts
fo
llo
w
-u
p
si
te
(th
eo
re
tic
al
pe
rs
pe
ct
iv
e)
C
om
m
en
ts
C
ox
,2
00
62
5
N
O
P
at
ie
nt
s
(n
=
54
),
G
P
s
(n
=
38
),
H
os
pi
ta
l
Lu
ng
S
ur
ve
y
qu
es
tio
nn
ai
re
s,
on
Q
ua
lit
at
iv
e
el
em
en
to
fs
tu
dy
po
or
ly
re
po
rt
ed
an
d
in
pl
ac
es
U
K
re
la
tiv
es
(n
=
20
),
cl
in
ic
al
st
af
f
(p
ar
tic
ip
an
ts
vi
gn
et
te
s;
in
-d
ep
th
in
te
rv
ie
w
s
di
ffi
cu
lt
to
fo
llo
w
.N
o
ra
tio
na
le
gi
ve
n
fo
r
se
le
ct
in
g
ra
nd
om
in
vo
lv
ed
in
pa
tie
nt
ca
re
(n
=
31
).
gi
ve
n
vi
gn
et
te
(G
ro
un
de
d
th
eo
ry
)
sa
m
pl
e
fo
r
in
te
rv
ie
w
s;
pu
rp
os
iv
e
sa
m
pl
e
m
ig
ht
(R
es
po
ns
e
ra
te
s:
pa
tie
nt
s
63
%
,
sc
en
ar
io
s
of
4
ha
ve
be
en
m
or
e
ap
pr
op
ria
te
.P
at
ie
nt
an
d
re
la
tiv
e
vi
ew
s
re
la
tiv
es
50
%
,s
ta
ff
65
%
,G
P
s
29
%
)
m
et
ho
ds
of
re
po
rt
ed
se
pa
ra
te
ly
to
st
af
fa
nd
G
P
s,
bu
tn
ot
cl
ea
r
w
hy
.
60
/7
2
el
ig
ib
le
pa
tie
nt
s
ap
pr
oa
ch
ed
fo
llo
w
-u
p:
W
he
n
di
ffe
re
nt
th
em
es
em
er
ge
d
fro
m
sa
m
e
in
te
rv
ie
w
to
pa
rt
ic
ip
at
e;
54
ag
re
ed
an
d
34
te
le
ph
on
e,
sc
he
du
le
,e
xp
lo
ra
tio
n
of
di
ffe
re
nc
es
an
d
ov
er
la
ps
in
re
tu
rn
ed
th
e
qu
es
tio
nn
ai
re
.
nu
rs
e,
G
P,
co
nc
er
ns
w
as
m
is
si
ng
R
an
do
m
sa
m
pl
e
of
re
sp
on
de
rs
co
nv
en
tio
na
l
in
te
rv
ie
w
ed
(6
/2
1
pa
tie
nt
s
ho
sp
ita
l)
ag
re
ed
to
be
in
te
rv
ie
w
ed
pl
us
3
re
la
tiv
es
,4
st
af
f,
an
d
2
G
P
s;
nu
m
be
r
ap
pr
oa
ch
ed
no
ts
ta
te
d)
Ji
w
a,
20
06
26
N
O
R
ep
re
se
nt
at
iv
es
fro
m
si
x
H
os
pi
ta
l
B
re
as
t
3
fo
cu
s
gr
ou
ps
—
O
nl
y
lim
ite
d
re
su
lts
fro
m
fo
cu
s
gr
ou
ps
pr
es
en
te
d
an
d
lin
ks
U
K
st
ak
eh
ol
de
r
gr
ou
ps
:G
P
s,
pr
ac
tic
e
(d
is
cu
ss
io
ns
6–
8
pa
rt
ic
ip
an
ts
.N
om
in
al
be
tw
ee
n
qu
ot
es
an
d
te
xt
no
ta
lw
ay
s
cl
ea
r.
R
at
io
na
lf
or
nu
rs
es
,b
re
as
tc
ar
e
nu
rs
e
ab
ou
te
ss
en
tia
l
gr
ou
p
—
re
pr
es
en
ta
tiv
es
re
cr
ui
tin
g
pa
tie
nt
s
no
tr
ep
or
te
d.
S
tu
dy
di
d
no
ts
ee
k
to
sp
ec
ia
lis
ts
,o
nc
ol
og
is
ts
,s
ur
ge
on
s
el
em
en
ts
fro
m
fo
cu
s
gr
ou
ps
de
sc
rib
e
in
di
vi
du
al
ex
pe
rie
nc
es
an
d
in
si
gh
ts
;f
oc
us
gr
ou
ps
or
sp
ec
ia
lis
ts
re
gi
st
ra
rs
,a
nd
of
a
m
od
el
of
(N
ot
st
at
ed
)
us
ed
to
id
en
tif
y
ba
rr
ie
rs
to
pr
im
ar
y
ca
re
fo
llo
w
-u
p
pa
tie
nt
s
(n
um
be
r
of
pa
rt
ic
ip
an
ts
pr
im
ar
y
ca
re
(d
ef
in
iti
ve
lis
to
fb
ar
rie
rs
no
tr
ep
or
te
d)
an
d
no
m
in
al
gr
ou
p
no
ts
ta
te
d)
fo
llo
w
-u
p)
m
ee
tin
gs
us
ed
as
a
pr
ob
le
m
so
lv
in
g
ex
er
ci
se
Jo
ha
ns
so
n,
20
00
27
Y
E
S
—
G
P
s
(n
=
20
).
Ta
ke
n
fro
m
sa
m
pl
e
In
te
gr
at
ed
M
ul
tip
le
S
em
i-s
tr
uc
tu
re
d
te
le
ph
on
e
C
ha
ra
ct
er
is
tic
s
of
in
cl
ud
ed
G
P
s
no
td
es
cr
ib
ed
.D
at
a
N
or
w
ay
In
te
rv
en
tio
n
+
of
10
0
G
P
s
re
po
rt
ed
as
be
in
g
ho
sp
ita
l
si
te
in
te
rv
ie
w
s
an
al
ys
ed
qu
an
tit
at
iv
el
y.
Ty
pe
an
d
nu
m
be
r
of
st
at
is
tic
al
co
nt
ro
lg
ro
up
pe
rs
on
al
G
P
s
to
a
se
le
ct
io
n
of
an
d
G
P
(N
ot
st
at
ed
)
te
st
s
ca
rr
ie
d
ou
tn
ot
st
at
ed
;o
nl
y
st
at
is
tic
al
ly
si
gn
ifi
ca
nt
(e
xt
en
de
d
pa
tie
nt
s
in
cl
ud
ed
in
tr
ia
l;
83
re
ce
iv
ed
fin
di
ng
s
re
po
rt
ed
.D
ef
in
iti
on
of
so
m
e
ca
te
go
rie
s
un
cl
ea
r.
in
fo
rm
at
io
n
to
ex
te
nd
ed
in
fo
rm
at
io
n
fro
m
se
co
nd
ar
y
In
te
rv
en
tio
n
st
ar
te
d
at
tim
e
of
di
ag
no
si
s,
no
tf
ol
lo
w
-u
p
G
P
s
+
ho
sp
ita
l
ca
re
as
pa
rt
of
in
te
rv
en
tio
n
an
d
17
fo
llo
w
-u
p
ha
d
no
t.
Te
n
pa
tie
nt
s
in
iti
al
ly
se
le
ct
ed
vs
ho
sp
ita
l
fro
m
th
os
e
w
ho
ha
d
no
tr
ec
ei
ve
d
fo
llo
w
-u
p)
53
in
te
rv
en
tio
n,
th
en
10
m
at
ch
in
g
G
P
s
se
le
ct
ed
fro
m
th
os
e
w
ho
re
ce
iv
ed
in
te
rv
en
tio
n.
52
7
pa
tie
nt
s
ra
nd
om
is
ed
as
pa
rt
of
or
ig
in
al
tr
ia
l,4
2
of
w
hi
ch
26
0
(4
9%
)r
ep
or
te
d
a
pe
rs
on
al
G
P
K
oi
nb
er
g,
20
01
29
Y
E
S
—
C
on
tro
l
P
at
ie
nt
s
(n
=
20
)
H
os
pi
ta
l
B
re
as
t
S
em
i-s
tr
uc
tu
re
d
in
te
rv
ie
w
s
Fa
irl
y
w
el
lc
on
du
ct
ed
st
ud
y.
D
iv
er
se
,s
tr
at
eg
ic
sa
m
pl
e
us
ed
,b
ut
no
t
S
w
ed
en
gr
ou
p
on
ly
13
1
pa
tie
nt
s
ra
nd
om
is
ed
to
(P
he
no
m
en
og
ra
ph
y)
st
at
ed
ho
w
m
an
y
pa
tie
nt
s
ap
pr
oa
ch
ed
an
d
de
cl
in
ed
to
pa
rt
ic
ip
at
e.
(P
I-
nu
rs
e
co
nv
en
tio
na
lh
os
pi
ta
lf
ol
lo
w
-u
p
P
ilo
ti
nt
er
vi
ew
s
us
ed
to
te
st
re
le
va
nc
e
of
th
e
qu
es
tio
ns
an
d
va
lid
ity
in
vs
ho
sp
ita
l)5
4
re
la
tio
n
to
ai
m
s.
H
ow
ev
er
,a
im
s
w
er
e
to
ex
am
in
e
pa
tie
nt
s’
sa
tis
fa
ct
io
n
an
d
re
su
lts
re
la
te
d
to
pa
tie
nt
s’
pe
rc
ei
ve
d
ne
ed
s.
R
es
ea
rc
he
rw
as
a
nu
rs
e
on
co
lo
gi
st
,a
nd
no
tc
le
ar
if
th
is
w
as
lik
el
y
to
af
fe
ct
pa
tie
nt
s’
re
sp
on
se
s.
A
na
ly
si
s
co
nd
uc
te
d
by
th
re
e
re
se
ar
ch
er
s.
K
oi
nb
er
g,
20
02
28
Y
E
S
—
In
te
rv
en
tio
n
P
at
ie
nt
s
(n
=
19
)
P
I-
nu
rs
e
B
re
as
t
S
em
i-s
tr
uc
tu
re
d
in
te
rv
ie
w
s
S
am
e
co
m
pa
ra
tiv
e
st
ud
y
as
ab
ov
e
(K
oi
nb
er
g,
20
01
29
)
S
w
ed
en
gr
ou
p
on
ly
13
3
pa
tie
nt
s
ra
nd
om
is
ed
to
(P
he
no
m
en
og
ra
ph
y)
(P
I-
nu
rs
e
vs
ho
sp
ita
l)5
4
re
ce
iv
e
in
te
rv
en
tio
n
...
co
nt
in
ue
d
Ta
b
le
1
co
nt
in
ue
d
.S
um
m
ar
y
o
f
ty
p
e
o
f
p
ar
ti
ci
p
an
ts
in
cl
ud
ed
in
q
ua
lit
at
iv
e
st
ud
y
co
nt
in
ue
d
.
British Journal of General Practice, July 2009 e253
Systematic Reviews
P
ar
to
fR
C
T?
Ty
pe
of
C
an
ce
r
S
tu
dy
ty
pe
S
tu
dy
an
d
co
un
tr
y
(tr
ia
lr
ef
er
en
ce
)
P
ar
tic
ip
an
ts
fo
llo
w
-u
p
si
te
(th
eo
re
tic
al
pe
rs
pe
ct
iv
e)
C
om
m
en
ts
M
cI
lv
en
ey
,2
00
43
0
N
O
P
at
ie
nt
s
(n
=
6)
N
ur
se
(c
lin
ic
)
B
re
as
t
S
em
i-s
tr
uc
tu
re
d
P
oo
rly
re
po
rt
ed
.I
nt
er
vi
ew
s
co
nd
uc
te
d
an
d
an
al
ys
ed
by
si
ng
le
re
se
ar
ch
er
—
U
K
H
C
P
s
(n
=
5,
fro
m
(3
pa
tie
nt
s
ha
d
in
te
rv
ie
w
s
br
ea
st
ca
nc
er
nu
rs
e
sp
ec
ia
lis
tw
ho
m
an
ag
ed
nu
rs
e-
le
d
fo
llo
w
-u
p
cl
in
ic
fro
m
m
ul
tid
is
ci
pl
in
ar
y
te
am
)
at
te
nd
ed
nu
rs
e-
(G
ro
un
de
d
th
eo
ry
)
w
hi
ch
pa
rt
ic
ip
an
ts
w
er
e
re
cr
ui
te
d.
N
o
m
ea
su
re
s
to
ad
dr
es
s
po
ss
ib
ili
ty
of
bi
as
le
d
fo
llo
w
-u
p,
3
re
po
rt
ed
.P
at
ie
nt
s
re
cr
ui
te
d
vi
a
ad
ve
rt
po
st
ed
in
ou
t-
pa
tie
nt
s;
no
tc
le
ar
ho
w
no
ty
et
at
te
nd
ed
)
pa
rt
ic
ip
an
ts
se
le
ct
ed
or
ho
w
m
an
y
re
fu
se
d
to
pa
rt
ic
ip
at
e.
S
om
e
qu
es
tio
ns
in
th
e
in
te
rv
ie
w
sc
he
du
le
s
no
tr
ep
or
te
d
in
re
su
lts
.I
n
so
m
e
in
st
an
ce
s
a
se
rie
s
of
qu
ot
at
io
ns
w
er
e
le
ft
to
‘s
pe
ak
fo
r
th
em
se
lv
es
’,
th
e
au
th
or
di
d
no
ts
um
m
ar
is
e
or
id
en
tif
y
th
e
po
in
tb
ei
ng
m
ad
e
M
oo
re
,2
00
63
1
Y
E
S
—
In
te
rv
en
tio
n
N
ur
se
s
(n
=
2
pr
ov
id
in
g
nu
rs
e-
le
d
N
ur
se
Lu
ng
S
em
i-s
tr
uc
tu
re
d
C
ha
ra
ct
er
is
tic
s
of
th
e
in
cl
ud
ed
nu
rs
es
an
d
st
ud
y
co
or
di
na
to
rs
no
td
es
cr
ib
ed
,
U
K
gr
ou
p
on
ly
fo
llo
w
-u
p)
an
d
re
se
ar
ch
(te
le
ph
on
e)
in
te
rv
ie
w
s,
ne
ith
er
w
as
ro
le
of
st
ud
y
co
-c
oo
rd
in
at
or
s.
In
te
rv
ie
w
s
co
nd
uc
te
d
fa
irl
y
ea
rly
(n
ur
se
-t
el
ep
ho
ne
co
or
di
na
to
rs
(n
=
2)
8
te
am
m
ee
tin
gs
on
in
th
e
ne
w
ro
le
so
nu
rs
es
ha
d
lit
tle
ex
pe
rie
nc
e
of
it;
qu
al
ita
tiv
e
in
te
rv
ie
w
s
vs
ho
sp
ita
l)8
(N
ot
st
at
ed
)
co
nd
uc
te
d
6
m
on
th
s
af
te
r
th
e
sp
ec
ia
lis
tn
ur
se
s
st
ar
te
d
w
or
ki
ng
on
th
e
tr
ia
l
w
ith
an
in
iti
al
3-
m
on
th
tr
ai
ni
ng
pe
rio
d
P
en
ne
ry
,2
00
03
2
N
O
P
at
ie
nt
s
(n
=
24
)
H
os
pi
ta
l
B
re
as
t
S
em
i-s
tr
uc
tu
re
d
P
oo
rly
re
po
rt
ed
st
ud
y.
Ve
ry
lit
tle
in
fo
rm
at
io
n
gi
ve
n
ab
ou
tt
he
qu
al
ita
tiv
e
U
K
P
at
ie
nt
s
se
le
ct
ed
fro
m
cl
in
ic
lis
t;
in
te
rv
ie
w
s
ap
pr
oa
ch
an
d
pr
oc
es
s
us
ed
.N
ot
cl
ea
r
ho
w
m
uc
h
of
th
e
fin
di
ng
s
w
er
e
24
/3
8
(6
3%
)a
gr
ee
d
to
pa
rt
ic
ip
at
e
(P
he
no
m
en
og
ra
ph
y)
re
sp
on
se
s
to
cl
os
ed
qu
es
tio
ns
(a
nd
th
e
ac
tu
al
qu
es
tio
ns
us
ed
w
er
e
no
t
re
po
rt
ed
).
In
te
rv
ie
w
s
co
nd
uc
te
d
by
le
ct
ur
er
pr
ac
tit
io
ne
ri
n
br
ea
st
ca
re
an
d
th
ei
rp
ot
en
tia
li
nf
lu
en
ce
du
rin
g
qu
es
tio
nn
ai
re
de
si
gn
,d
at
a
co
lle
ct
io
n,
an
d
da
ta
an
al
ys
is
w
er
e
no
te
xa
m
in
ed
R
oz
m
ov
its
,2
00
41
2
N
O
P
at
ie
nt
s
(n
=
39
)
H
os
pi
ta
l
C
ol
or
ec
ta
l
In
-d
ep
th
P
at
ie
nt
s
re
cr
ui
te
d
vi
a
G
P
s,
ho
sp
ita
lc
on
su
lta
nt
,a
nd
su
pp
or
to
rg
an
is
at
io
ns
to
U
K
in
te
rv
ie
w
s
pa
rt
ic
ip
at
e
in
an
in
te
rv
ie
w
fo
r
th
e
D
IP
E
x
pr
oj
ec
t(
a
da
ta
ba
se
of
pa
tie
nt
s’
(N
ot
st
at
ed
)
ex
pe
rie
nc
es
).
N
ot
cl
ea
r
ho
w
m
an
y
pa
tie
nt
s
re
fu
se
d
to
pa
rt
ic
ip
at
e
S
ah
ay
,2
00
03
3
N
O
P
at
ie
nt
s
(n
=
20
)
H
os
pi
ta
l
C
ol
or
ec
ta
l
S
em
i-s
tr
uc
tu
re
d
In
te
rv
ie
w
sc
he
du
le
co
ve
re
d
di
ag
no
si
s,
tr
ea
tm
en
ta
nd
ca
re
(n
ot
ju
st
fo
llo
w
-u
p)
.
C
an
ad
a
te
le
ph
on
e
N
o
ra
tio
na
le
gi
ve
n
fo
r
sa
m
pl
e
ch
os
en
an
d
no
in
fo
rm
at
io
n
gi
ve
n
ab
ou
tt
he
in
te
rv
ie
w
s.
nu
m
be
r
of
pa
tie
nt
s
ap
pr
oa
ch
ed
or
de
cl
in
ed
(a
nd
re
as
on
w
hy
).
N
um
be
r
of
(N
ot
st
at
ed
)
qu
ot
es
w
as
lim
ite
d
an
d
th
os
e
pr
es
en
te
d
w
er
e
no
ti
de
nt
ifi
ed
.I
nt
er
vi
ew
sc
he
du
le
in
cl
ud
ed
in
te
re
st
in
g
qu
es
tio
ns
bu
tf
ar
m
or
e
th
an
co
ul
d
be
co
ve
re
d
in
de
pt
h
in
a
1-
ho
ur
in
te
rv
ie
w
.S
om
e
qu
es
tio
ns
m
is
se
d
or
on
ly
to
uc
he
d
on
br
ie
fly
in
an
al
ys
is
W
on
g,
20
02
34
N
O
P
at
ie
nt
s
(n
=
41
)
H
os
pi
ta
l
M
ul
tip
le
Fo
cu
s
gr
ou
ps
—
A
im
s
w
er
e
to
un
de
rs
ta
nd
pa
tie
nt
ex
pe
rie
nc
es
as
w
el
la
s
id
en
tif
y
co
nc
er
ns
,
C
hi
na
(H
on
g
K
on
g)
si
te
4–
7
pa
rt
ic
ip
an
ts
le
ve
ls
of
sa
tis
fa
ct
io
n,
an
d
so
ur
ce
s
of
di
ss
at
is
fa
ct
io
n
w
ith
fo
llo
w
-u
p
ca
re
,
(N
ot
st
at
ed
)
bu
tr
es
ul
ts
(a
nd
ho
w
da
ta
an
al
ys
ed
)f
oc
us
ed
on
pa
tie
nt
s’
co
nc
er
ns
.S
am
pl
e
si
ze
w
as
no
tj
us
tif
ie
d.
P
at
ie
nt
s
re
cr
ui
te
d
vi
a
ne
tw
or
k
of
ca
nc
er
pa
tie
nt
se
lf-
he
lp
gr
ou
ps
;s
am
pl
e
bi
as
ed
to
w
ar
ds
a
yo
un
ge
r
an
d
m
or
e
kn
ow
le
dg
ea
bl
e
pa
tie
nt
gr
ou
p.
N
ot
st
at
ed
ho
w
in
di
vi
du
al
gr
ou
ps
se
le
ct
ed
pa
tie
nt
s
an
d
if
an
y
de
cl
in
ed
to
ta
ke
pa
rt
.D
at
a
ap
pe
ar
s
to
ha
ve
be
en
an
al
ys
ed
in
rig
or
ou
s
w
ay
an
d
cr
ed
ib
ili
ty
of
fin
di
ng
s
ar
e
di
sc
us
se
d.
B
ut
in
su
ffi
ci
en
td
at
a
ar
e
pr
es
en
te
d
to
su
pp
or
tt
he
fin
di
ng
s,
su
ch
as
na
rr
at
iv
e
qu
ot
es
W
oo
d,
19
96
35
N
O
O
nc
ol
og
is
ts
(n
=
9)
H
os
pi
ta
l
M
ul
tip
le
S
em
i-s
tr
uc
tu
re
d
Fa
irl
y
w
el
lc
on
du
ct
ed
an
d
re
po
rt
ed
st
ud
y.
S
am
pl
in
g
m
et
ho
d
an
d
si
ze
cl
ea
rly
C
an
ad
a
si
te
in
te
rv
ie
w
s
de
sc
rib
ed
an
d
ju
st
ifi
ed
,b
ut
no
tr
ep
or
te
d
ho
w
pa
rt
ic
ip
an
ts
re
cr
ui
te
d
or
ho
w
(P
he
no
m
en
og
ra
ph
y)
st
ud
y
ex
pl
ai
ne
d
to
th
em
.D
at
a
co
lle
ct
io
n
ca
rr
ie
d
ou
ta
pp
ro
pr
ia
te
ly
,b
ut
de
ta
ils
of
in
te
rv
ie
w
gu
id
e
(u
se
d
to
re
du
ce
in
te
rv
ie
w
er
bi
as
)n
ot
re
po
rt
ed
.S
uf
fic
ie
nt
da
ta
pr
es
en
te
d
to
su
pp
or
tf
in
di
ng
s,
bu
ts
ou
rc
e
of
qu
ot
es
no
tg
iv
en
.
D
IP
E
x
=
D
at
ab
as
e
of
In
d
iv
id
ua
lP
at
ie
nt
E
xp
er
ie
nc
es
(n
ow
ca
lle
d
he
al
th
ta
lk
on
lin
e:
w
w
w
.h
ea
lth
ta
lk
on
lin
e.
or
g)
.H
os
p
ita
l=
co
nv
en
tio
na
lc
on
su
lta
nt
-l
ed
ho
sp
ita
lf
ol
lo
w
-u
p
.H
C
P
s
=
he
al
th
ca
re
p
ro
fe
ss
io
na
ls
.P
I=
p
at
ie
nt
in
iti
at
ed
.R
C
T
=
ra
nd
om
is
ed
co
nt
ro
lle
d
tr
ia
l.
Ta
b
le
1
co
nt
in
ue
d
.S
um
m
ar
y
o
f
ty
p
e
o
f
p
ar
ti
ci
p
an
ts
in
cl
ud
ed
in
q
ua
lit
at
iv
e
st
ud
y
co
nt
in
ue
d
.
British Journal of General Practice, July 2009
RA Lewis, RD Neal, M Hendry, et al
e254
R
ef
er
en
ce
nu
m
b
er
a
R
es
ea
rc
h
q
ue
st
io
n
19
20
21
1
22
23
24
25
26
27
29
28
30
31
32
12
33
34
35
D
id
th
e
ar
tic
le
d
es
cr
ib
e
an
im
p
or
ta
nt
cl
in
ic
al
p
ro
b
le
m
ex
am
in
ed
vi
a
±
+
+
+
+
+
+
+
+
±
±
+
+
±
+
±
±
+
+
a
cl
ea
rly
fo
rm
ul
at
ed
q
ue
st
io
n?
W
as
th
e
q
ua
lit
at
iv
e
ap
p
ro
ac
h
ap
p
ro
p
ria
te
?
+
+
+
+
+
+
+
+
+
±
+
+
+
+
+
+
+
+
+
S
am
p
lin
g
m
et
ho
d
W
as
th
e
sa
m
p
lin
g
st
ra
te
gy
cl
ea
rly
d
ef
in
ed
?
–
±
±
+
–
±
+
–
±
±
±
±
±
+
+
+
–
+
+
W
as
th
e
sa
m
p
lin
g
st
ra
te
gy
an
d
si
ze
ju
st
ifi
ed
?
–
±
–
±
–
±
+
–
–
±
±
±
+
+
±
+
–
–
±
W
as
th
e
sa
m
p
lin
g
st
ra
te
gy
ap
p
ro
p
ria
te
?
–
–
–
+
±
?
+
–
+
+
±
±
+
+
±
+
?
±
+
Is
it
cl
ea
r
w
hy
so
m
e
p
ar
tic
ip
an
ts
ch
os
e
no
t
to
ta
ke
p
ar
t?
–
–
±
±
–
–
±
–
–
N
A
–
–
–
N
A
–
–
–
–
+
H
av
e
th
e
ch
ar
ac
te
ris
tic
s
of
in
cl
ud
ed
su
b
je
ct
s
b
ee
n
cl
ea
rly
d
ef
in
ed
?
–
±
–
±
–
–
+
–
–
±
+
+
+
–
±
+
+
+
±
D
at
a
co
lle
ct
io
n
W
as
th
e
se
tt
in
g
ju
st
ifi
ed
?
±
+
±
+
?
±
+
±
+
+
+
+
+
+
+
+
±
+
+
W
er
e
th
e
m
et
ho
d
s
us
ed
fo
r
co
lle
ct
in
g
d
at
a
d
es
cr
ib
ed
in
en
ou
gh
d
et
ai
l?
±
+
±
+
±
–
–
–
+
±
+
+
+
+
–
+
±
–
±
W
er
e
th
e
d
at
a
co
lle
ct
io
n
m
et
ho
d
s
re
lia
b
le
an
d
ve
rif
ia
b
le
?
±
+
±
+
±
–
+
?
+
±
+
±
–
+
+
+
+
+
+
W
er
e
ob
se
rv
at
io
ns
ta
ke
n
in
a
ra
ng
e
of
ci
rc
um
st
an
ce
s
–
N
A
?
N
A
–
±
+
N
A
N
A
–
–
–
?
–
–
+
N
A
–
N
A
(fo
r
ex
am
p
le
,
at
d
iff
er
en
t
tim
es
)?
R
el
at
io
ns
hi
p
b
et
w
ee
n
re
se
ar
ch
er
an
d
p
ar
ti
ci
p
an
ts
W
as
th
e
re
se
ar
ch
er
’s
p
er
sp
ec
tiv
e/
ro
le
d
es
cr
ib
ed
?
–
–
–
–
–
–
+
–
±
–
+
+
–
+
±
–
–
–
+
W
as
th
e
re
se
ar
ch
er
’s
p
er
sp
ec
tiv
e/
ro
le
lik
el
y
to
le
ad
to
p
ot
en
tia
l
?
?
–
?
?
?
±
?
±
?
±
±
–
–
±
?
?
?
±
b
ia
s
or
in
flu
en
ce
?
D
o
th
e
re
se
ar
ch
er
s
st
at
e
ho
w
th
e
re
se
ar
ch
w
as
ex
p
la
in
ed
–
+
–
±
–
–
+
–
–
±
+
+
+
?
–
–
±
–
–
to
th
e
p
ar
tic
ip
an
ts
?
D
at
a
an
al
ys
is
Is
it
cl
ea
r
ho
w
th
e
ca
te
go
rie
s/
th
em
es
w
er
e
d
er
iv
ed
fr
om
th
e
d
at
a?
–
+
±
+
–
–
–
±
+
+
+
+
±
+
±
±
±
+
±
W
er
e
st
ep
s
ta
ke
n
to
te
st
th
e
cr
ed
ib
ili
ty
of
th
e
fin
d
in
gs
?
–
–
–
±
–
–
–
–
–
+
±
±
–
±
–
+
?
±
+
W
er
e
al
lt
he
d
at
a
ta
ke
n
in
to
ac
co
un
t
in
th
e
an
al
ys
is
?
–
+
+
?
?
?
?
?
?
?
+
+
–
?
?
?
?
?
?
W
er
e
ne
ga
tiv
e
or
d
is
cr
ep
an
t
re
su
lts
fu
lly
ad
d
re
ss
ed
,
or
ju
st
ig
no
re
d
?
?
?
?
?
?
?
±
?
?
?
?
?
?
?
?
+
–
?
±
D
o
th
e
re
su
lts
ad
d
re
ss
th
e
re
se
ar
ch
q
ue
st
io
n?
+
+
+
+
±
+
±
±
+
+
±
±
±
+
+
+
±
+
±
Is
su
ffi
ci
en
t
d
at
a
p
re
se
nt
ed
to
su
p
p
or
t
th
e
fin
d
in
gs
?
±
+
+
+
–
–
–
–
–
±
±
±
+
+
±
+
±
–
±
D
o
th
e
re
se
ar
ch
er
s
ex
p
la
in
ho
w
th
e
d
at
a
p
re
se
nt
ed
in
th
e
p
ap
er
w
er
e
–
–
–
–
–
–
–
–
–
±
+
+
–
+
–
–
–
–
–
se
le
ct
ed
fr
om
th
e
or
ig
in
al
sa
m
p
le
?
Is
it
p
os
si
b
le
to
d
et
er
m
in
e
th
e
so
ur
ce
s
of
d
at
a
p
re
se
nt
ed
?
+
+
+
+
–
–
–
+
+
–
±
–
+
+
+
+
–
–
–
C
o
nc
lu
si
o
ns
A
re
th
e
co
nc
lu
si
on
s
ju
st
ifi
ed
b
y
th
e
re
su
lts
?
±
±
±
+
±
?
±
±
+
±
±
±
+
+
±
±
+
±
±
H
av
e
al
te
rn
at
iv
e
ex
p
la
na
tio
ns
fo
r
th
e
re
su
lts
b
ee
n
ex
p
lo
re
d
an
d
–
–
±
–
–
–
–
–
–
±
±
±
–
–
±
±
–
–
–
d
is
co
un
te
d
?
W
er
e
th
e
lim
ita
tio
ns
of
th
e
st
ud
y
d
is
cu
ss
ed
?
–
+
±
–
–
–
–
–
+
±
±
–
±
+
–
–
–
+
–
A
re
th
e
fin
d
in
gs
of
th
e
st
ud
y
tr
an
sf
er
ab
le
to
ot
he
r
cl
in
ic
al
se
tt
in
gs
?
?
?
±
?
–
?
–
?
–
±
–
–
?
–
±
?
?
–
+
+
ite
m
p
ro
p
er
ly
ad
d
re
ss
ed
;±
ite
m
p
ar
tia
lly
ad
d
re
ss
ed
;–
ite
m
no
t
p
ro
p
er
ly
ad
d
re
ss
ed
;?
U
nc
le
ar
/c
an
’t
te
ll/
no
t
st
at
ed
;N
A
N
ot
ap
p
lic
ab
le
.
Ta
b
le
2.
S
um
m
ar
y
o
f
th
e
q
ua
lit
y
as
se
ss
m
en
t
o
f
q
ua
lit
at
iv
e
st
ud
ie
s.
British Journal of General Practice, July 2009
professionals felt that patients expected tests and
examinations, and were difficult to reassure without
them.1,26 For some patients an increase in the interval
between appointments was seen as a positive
sign,1,32 and anxiety diminished over time,23 but, for
others, anxiety persisted20,23,26 and even increased as
the interval lengthened.1,23
Specialist knowledge and quick access to tests were
thought to be the most important ingredients of
follow-up, and were key concepts of alternative
models. Access to expertise, including a team of
specialists with associated technology, engendered
confidence in patients and relatives and was the
main advantage of hospital-based follow-up.19,22,25,32
Patients’ antagonism towards alternative models
was largely associated with concerns that it would
be difficult to re-access specialist facilities quickly if
required.22 GPs were considered by patients,12,19,23,32,33
and oncologists35 to lack specialist knowledge for
undertaking follow-up, identifying and treating
recurrence, or even supporting patients between
hospital appointments. However, GPs thought this
was not a barrier to involvement as they could get
information from specialists when needed.21 Cancer
specialist nurses were seen to be less
knowledgeable and experienced than doctors, but
had quick access to medical back up when
necessary.25,26
Information regarding the effectiveness of follow-up
(tests and examinations) was not given to patients.
Healthcare professionals admitted that patients were
given little or no explanation of follow-up and thought
patients would be more likely to accept alternative
models if they were fully explained.25,26 Patients were
unaware of flaws in conventional hospital follow-up.
Inconsistencies in surveillance protocols between
doctors and hospitals confused and worried
them.22,34 Tests and examinations appeared to
provide tangible evidence of freedom from
disease,12,19,23,25,29 and radiological tests were
considered to be particularly reliable by patients.20,23,25
However, healthcare professionals acknowledged
that examinations were unlikely to detect recurrence
in patients who were symptom-free.1,26
Patients lacked clear information that could aid
coping and enable involvement. Patients obtained
information from various sources (friends and
family,33 internet and support groups,12,33 GPs,33 and
hospital1,33,34), but still had unmet needs.12,19,21,25,28,29,32–34
Appropriate information reduced anxiety,23 provided
reassurance,23 helped them cope,23,34 and enabled
involvement.33,34 However, many were dissatisfied
with the limited information given in
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1. Patients should be given full and clear information using plain language on
the following:
 effectiveness of different tests and examinations in detecting recurrence;
 risk of recurrence and what they can do to reduce this;
 potential side-effects of treatment and how to deal with them;
 signs and symptoms of potential recurrence and what to do if these are
experienced; and
 alternative models of follow-up that may be available.
2. A follow-up care plan which has been negotiated with the patient/carer
should be set up for each patient on completing treatment, including the
patient’s preferred model of follow-up. Generally, patients’ main concern is
fear of recurrence and many find regular follow-up reassuring.
3. Healthcare professionals should provide sufficient time and encourage
patients during follow-up to raise questions and concerns.
4. Psychological support should be an integral part of follow-up, especially
during the initial stages.
5. Tests and examinations should not be conducted purely for reassurance, but
only where there is a reason or the evidence base to support their use; and
this must be explained to the patient/carer.
6. Patients should be given contact details of a key person whom they can
contact when needed and who can provide them with support and continuity
of care.
7. Multidisciplinary teams should include representation from primary care (but
this does not have to be the individual patient’s GP or someone from the
patient’s practice)
8. There needs to be a formal handover and exchange of information between
primary and secondary care. This should include complete discharge
information and exchange of contact details (hospital clinicians to GPs and
vice versa).
9. As an adjunct to routine hospital follow-up, a member of the primary care
team should make contact with the patient immediately after hospital
discharge to discuss the type of support that primary care could offer.
10.Patients should be given informed choice about whether to attend
scheduled appointments or just when they have problems or symptoms
(patient-initiated).
11.If alternative models of follow-up (for example, primary care, nurse, or
patient-initiated follow-up) are to be developed and tested in further
research, then these models should:
 include a system of rapid referral for investigations (to be explained to
patients);
 include training/education for GPs, nurses, and other healthcare
professionals;
 include support from specialist team at hospital (or medical support for
alternative models set up in secondary care);
 be established with the collaboration of the whole cancer team and
primary care from the outset; clear protocol/guidelines should be
agreed by all parties in advance; and
 enable individual GPs (for primary care follow-up) to be able to opt out;
alternative primary care-based follow-up should be provided if the
patient wishes this.
12.The role of cancer support groups needs to be explored further.
Box 1. Recommendations for policy and practice derived
from descriptive themes.
consultations,12,19,21,25,28,29,32–34 or felt advice was
inappropriate.12 Patients had difficulty understanding
medical terminology and thought technical language
was sometimes used as an excuse not to provide
adequate information.33,34 Clinic nurses interpreted
information for patients.1 Some patients felt inhibited
about asking questions.32,33 Some patients perceived
that more information was given to patients who
were better educated,34 or asked the right
questions.33,34
Continuity of care and unhurried consultations were
of major importance to patients. A good relationship
with the healthcare professional was valued by
patients, and continuity of care (seeing the same
person) was key to this.19–21,25,29,30,32,34 Patients
appreciated being seen by someone familiar who
knew their case.12,32 Having contact details of
healthcare professionals was considered important
and reassuring.12,25,32 Lack of continuity was a barrier
to good communication.30,34 Patients found that
nurses were easier to talk to than doctors and had
more time.25,30 The system of rotating junior doctors
interrupted continuity,34 and there was no time during
consultations to raise concerns or questions.1,19–21,32,33
Psychosocial support was important because of the
impact of cancer on patients’ lives (for example,
social, domestic, economic) but was under-provided.
Psychosocial support was very important to
patients,20,22,23,28,29,33 but patients and healthcare
professionals agreed that there was not enough time
for it in conventional follow-up.1,20,32 Some support
could be provided by family and friends,20,23,29
although some people were reluctant to burden
them.33 Some found GPs helpful,12,33 although others
lacked confidence in them to provide support.22
Specialist nurses had more time for psychosocial
support than doctors, and were particularly effective
in providing it.12,25,31,32
Patients were reluctant to use their GP for cancer-
related support (in between hospital visits). While a
few GPs were keen to participate in cancer care,21
and some patients received valuable support,12,33
many patients thought GPs were too busy,22,32 lacked
knowledge,23,25,33 or were not interested in cancer
care.12,22 Some GPs were understanding and helpful,
but patient–GP relationships could be undermined
by problems during diagnosis and initial referral,12 or
by lack of rapport.22
There were significant communication problems, in
both directions, between primary and secondary
care, which hindered GPs’ ability to provide support.
Multidisciplinary teams were thought to be very
important and to work well in the hospital setting,25,35
but the absence of a primary care representative
was thought a weakness.35 GPs felt uninformed, and
a formal handover with exchange of information at
the time of patients’ discharge from hospital was
identified (by GPs and hospital doctors) as most
important.21,26,27,35 In an RCT, GPs who were given
more information by the hospital felt more able to be
involved in follow-up, to determine patients’ needs,
and to offer support.27 Oncologists felt that they
were not kept informed by GPs and thought the
large number of GPs, their varied level of
commitment and knowledge, lack of time, and
difficulties in contacting them were barriers to
collaboration between specialists and primary
care.35 Patients’ preferences for either hospital or GP
follow-up were also seen to be detrimental to
collaboration and a team approach.35
Cancer specialist nurse-led follow-up could benefit
patients but some healthcare professionals lacked
confidence in it. Patients had confidence in nurse-led
follow-up, and women especially were thought to be
more comfortable with female nurses, but some
healthcare professionals did not think nurses were
experienced enough.30 A newly set-up nurse-led
telephone follow-up service was seen by specialist
nurses to provide effectively planned and managed
care in a more supportive environment that allowed
more involvement of the family in care.32 However,
the nurses experienced hostility and lack of support
from hospital staff, and it took time for them to
become confident in their role and to earn the
respect of other colleagues.31
Some thought that nurse-led follow-up was
inappropriate and that nurses were not skilled
enough to deal with the medical interventions and
palliative care required by lung cancer patients.31
Nurses reported that the role carried an enormous
emotional burden and that they needed supervision
and support, but that it was immensely satisfying.31
Clinic staff thought that nurse-led follow-up for lung
cancer could free up doctors’ time for patients with
medical needs, while patients thought it could give
access to expertise more quickly than conventional
follow-up.25 Clinical staff identified the essential
requirements for nurse-led follow-up (for lung cancer
patients) as: clear protocol and guidelines, access to
medical back-up, and training.25
GPs were not thought to be willing or to have
sufficient expertise to conduct primary care follow-
up. Patients lacked confidence in GPs to provide
follow-up, and those attending conventional hospital
follow-up chose GP-led follow-up as their least
preferred option from four models (nurse,
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conventional, telephone, and GP follow-up).22,25
Patients thought GPs would be unwilling to provide
follow-up,12,22 and healthcare professionals thought
they would need additional training first.26 Key
stakeholders thought that the essential requirements
for primary-care follow-up (for breast cancer
patients) included formal handover from secondary
care with a detailed case summary, a protocol for re-
referral to specialists, access to investigations, and
referral to a specialist counsellor.26,27 There was no
consensus on whether patients should have regular
follow-up appointments or make an appointment
when symptoms or concerns arose.26,29
Patient-initiated follow-up was convenient but less
reassuring. Some patients preferred the flexibility of
patient-initiated follow-up, but others preferred
regular appointments,29,32 in some cases because
they feared they would put off or fail to make an
appointment.23,32
DISCUSSION
Summary of main findings
Twelve descriptive themes were identified. Fear of
recurrence was the main concern for patients, which
was temporarily alleviated by attending routine
follow-up with cancer specialists. Information
regarding the limitations of routine hospital follow-up
(or lack of effectiveness of examinations and tests)
was not conveyed to patients, who also had unmet
needs for information, which would help them cope
and be more involved.
Continuity of care, unhurried consultation, and
psychosocial support were important to patients.
The expertise of hospital specialists and quick
access to tests were highly valued, but time,
emotional support, and continuity of care were
sometimes lacking in routine hospital follow-up.
Patients were reluctant to use their GP for cancer-
related support in between hospital visits, and GPs
were thought to be unwilling or to have insufficient
time and expertise to provide follow-up. There were
significant communication problems between
primary and secondary care, in both directions.
Specialist nurses were considered more supportive
than doctors, and patients were satisfied with nurse-
led follow-up but other health professionals lacked
confidence in it. Patient-initiated follow-up was more
convenient but less reassuring.
From the descriptive themes, 12 perceived
implications for policy and practice were derived.
Improved patient information is needed, which would
help them to cope and be more involved as well as
enable them to make informed choices about the
type of follow-up support they need. Patients valued
regular follow-up by specialists to allay fears of
disease recurrence. Psychological support should be
an integral part of follow-up, and sufficient time and
encouragement should be given for patients to raise
concerns and ask questions. Improved
communication between primary and secondary
care should be established from the outset, with a
formal handover and exchange of information at
discharge. The availability and type of primary care
support (as an adjunct to routine hospital follow-up)
should be conveyed to patients. Alternative models
of follow-up should be established with the support
of the whole cancer team (including input from
primary care), and include training and educational
support, and quick access to specialist tests.
Strengths and limitations of the study
The literature search was comprehensive, but it was
carried out separately for each cancer site, rather
than using generic cancer terms. Although the
searches identified studies evaluating multiple
cancer sites, it is not possible to be certain that none
was missed, especially studies examining cancer
survivorship among children or young adults, which
did not specify the cancer site. The quality of
included studies varied, with many being poorly
reported. However, there is debate about the use of
quality-assessment tools for appraising qualitative
studies.40–42 The included studies were
heterogeneous in terms of population studied,
underlying theory used, and methods of data
collection. Although there is some controversy about
the value of combining the findings from studies
using different methods or informed by different
theories of knowledge,43,44 this enabled the
researchers to identify a range of common themes.
Most included studies were related to conventional
follow-up in secondary care, which was the type of
follow-up that most had received. Some of the views
expressed concerning other models of care were
based on participants’ ideas, rather than their
experiences. The search only included qualitative
studies rather than quantitative surveys of
participants’ views, because the views expressed
were more likely to reflect those of the participants
rather than any perceived views or beliefs of the
researchers. It must be acknowledged that there is a
minor limitation that the potential prevalence of these
views and themes was not estimated.
The recommendations for policy are based on an
evaluation that goes beyond the findings of the
primary studies, and as such their development was
dependent on the judgement and insights of the
reviewers and their knowledge of relevant literature
from different sources. They were generated using
the same underlying rigorous process as the
inductive analysis and development of the
descriptive themes; accordingly, they are presented
within the results rather than the discussion. The
recommendations were initially developed by two
independent reviewers who are not clinicians. They
were then checked and commented on by two
further independent reviewers, one of whom is a
practising GP and the second a consultant
oncologist.
Comparison with existing literature
The authors are not aware of any other systematic
reviews that summarise the findings of peoples’
views on cancer follow-up.
Implications for future research and clinical
practice
Patients wanted regular consultations with cancer
specialists, tests, and examinations to allay fears of
disease recurrence. Healthcare professionals
admitted that patients were given little or no
explanation about follow-up, and patients felt that
appropriate information could help them to cope and
would enable involvement.
The evidence regarding the effectiveness of follow-
up should be discussed with patients, as well as their
own personal risk of recurrence including advice on
what they can do, if anything, to reduce this risk (for
example, there is evidence that exercise and a
reduced-fat diet can reduce the risk of breast cancer
recurrence45–47). In a survey of 156 colorectal cancer
patients attending routine hospital follow-up, only
22% could identify risk indicators for recurrence,
while 64% said they would like to be told what to
look for.48
Patients may also benefit from education and
information on how to cope psychologically, and
self-management strategies for common problems.
The opportunities for patients to participate actively
in their own post-treatment care were not discussed
in any of the primary studies, nor how such
opportunities could be built into any model of cancer
follow-up.
To enable comprehensive patient care and for
patients to have the support they need, improved
communication between primary and secondary
care is needed in both directions, irrespective of the
type of follow-up used. National Institute for Health
and Clinical Excellence guidance on breast and
colorectal cancer recommends that the
multidisciplinary team responsible for the patient
should maintain close contact with GPs and primary
care teams,49,50 and should take responsibility for
passing clinical information in a timely manner to the
GP, irrespective of the type of follow-up. Having a GP
with a special interest in cancer as a member of the
multidisciplinary team, who could act as a
representative or spokesperson for primary care,
could be beneficial.
Most of the qualitative studies included patients
who had not experienced alternative types of follow-
up; they were mainly patients who had recently
completed treatment or who had received
conventional hospital follow-up. More qualitative
studies are needed of patients who have
experienced other forms of follow-up. Further
research specifically focusing on preferences and
experiences (as opposed to views and attitudes)
would also be welcomed in this topic. More
qualitative studies are also needed of cancer sites
not covered by included studies.
Further research is needed to evaluate whether
patients’ preference for routine follow-up is changed
if they are given clear information about the
effectiveness of diagnostic tests and investigations,
their risk of recurrence, how to recognise signs and
symptoms of recurrence, and any preventative
measures they could take. Patients value the
psychological support provided by routine hospital
follow-up. Further research is needed to assess the
type of psychological support that patients want or
need, and how best to provide this within the context
of alternative models of follow-up.
Funding body
Cancer Research UK (Ref C8350/A4543). The funding
source had no involvement in the study
Ethical approval
Ethical approval was not required
Competing interests
The authors have stated that there are none
Acknowledgments
We would like to thank Stephen Duffy for his advice on
searching databases and developing the search strategy,
Bernadette Coles and Hilary Kitcher for checking some of the
original search strategies, Madeline Pasterfield and Jennifer
Wilkinson for technical support including carrying out the
update searches, and Alison Eastwood for peer reviewing the
protocol and draft final report. We would also like to thank the
following people for sending us further information about the
studies they had conducted: Kinta Beaver, Gillian Knowles,
Karen Cox, Christine McIlvenney, and Stephen Barclay.
Thanks also to Richard Bailey and his staff at the John
Spalding Library for their help in retrieving manuscripts.
Discuss this article
Contribute and read comments about this article on the
Discussion Forum: http://www.rcgp.org.uk/bjgp-discuss
REFERENCES
1. Beaver K, Luker K. Follow-up in breast cancer clinics: reassuring for
patients rather than detecting recurrence. Psychooncology 2005; 14(2):
94–101.
2. Rojas MP, Telaro E, Russo A, et al. Follow-up strategies for women
treated for early breast cancer.Cochrane Database Syst Rev 2000; (4):
CD001768.
3. Somerfield MR, Schapira DV, Davidson NE, et al. Recommended
breast cancer surveillance guidelines. J Clin Oncol 1997; 15(5):
2149–2156.
4. Collins RF, Bekker HL, Dodwell DJ. Follow-up care of patients treated
for breast cancer: a structured review. Cancer Treat Rev 2004; 30(1):
19–35.
5. Botteman MF, Pashos CL, Redaelli A, et al. The health economics of
British Journal of General Practice, July 2009
RA Lewis, RD Neal, M Hendry, et al
e258
British Journal of General Practice, July 2009 e259
Original PapersSystematic Review
bladder cancer: a comprehensive review of the published literature.
Pharmacoeconomics 2003; 21(18): 1315–1330.
6. Francken AB, Bastiaannet E, Hoekstra HJ. Follow-up in patients with
localised primary cutaneous melanoma. Lancet Oncol 2005; 6(8):
608–621.
7. Pascoe SW, Neal RD, Allgar VL, et al. Psychosocial care for cancer
patients in primary care — recognition of opportunities for cancer
care. Fam Pract 2004; 21(4): 437–442.
8. Moore S, Corner J, Haviland J, et al. Nurse led follow up and
conventional medical follow up in management of patients with lung
cancer: randomised trial. BMJ 2002; 325(7373): 1145–1147.
9. Ham C. Gordon Brown’s agenda for the NHS [editorial]. BMJ 2008;
336(7935): 53–54.
10. Campbell R, Pound P, Pope C, et al. Evaluating meta-ethnography: a
synthesis of qualitative research on lay experiences of diabetes and
diabetes care. Soc Sci Med 2003; 56(4): 671–684.
11. Griffin SJ, Kinmonth AJ, Skinner C, Kelly J. Education and
psychosocial interventions for adults with diabetes. London: British
Diabetic Association, 1999.
12. Rozmovits L, Rose P, Ziebland S. In the absence of evidence, who
chooses? A qualitative study of patients’ needs after treatment for
colorectal cancer. J Health Serv Res Policy 2004; 9(3): 159–164.
13. Lewis RA, Neal RD,Williams NH, et al. Follow-up of cancer in
primary care versus secondary care: systematic review. Br J Gen Pract
2009; 59: 525–532.
14. Lewis R, Neal RD,Williams NH, et al. Nurse-led vs conventional
physician-led follow-up for patients with cancer: systematic review. J
Adv Nurs 2009; 65: 706–723.
15. Thomas J, Harden A. Methods for the thematic synthesis of
qualitative research in systematic reviews. BMCMed Res Methodol
2008; 8: 45. DOI: 10.1186/1471-2288-8-45
16. Harden A, Garcia J, Oliver S, et al. Applying systematic review
methods to studies of people’s views: an example from public health
research. J Epidemiol Community Health 2004; 58(9): 794–800.
17. Critical Appraisal Skills Programme (CASP).Critical Appraisal Skills
Programme (CASP) making sense of evidence. Oxford: Public Health
Resource Unit (PHRU), 2006.
http://www.phru.nhs.uk/Doc_Links/Qualitative%20Appraisal%20Tool
.pdf
18. Greenhalgh T, Taylor R. How to read a paper: papers that go beyond
numbers (qualitative research). BMJ 1997; 315(7110): 740–743.
19. Adewuyi-Dalton R, Ziebland S, Grunfeld E, Hall A. Patients’ views of
routine hospital follow-up: a qualitative study of women with breast
cancer in remission. Psychooncology 1998; 7(5): 436–439.
20. Allen A. The meaning of the breast cancer follow-up experience for
the women who attend. Eur J Oncol Nurs 2002; 6(3): 155–161.
21. Anvik T, Holtedahl KA, Mikalsen H. ‘When patients have cancer, they
stop seeing me’ — the role of the general practitioner in early follow-
up of patients with cancer — a qualitative study. BMC Fam Pract
2006; 7: 19.
22. Bradburn J, Maher J, Adewuyidalton R, et al. Developing clinical-trial
protocols — the use of patient focus groups. Psychooncology 1995;
4(2): 107–112.
23. Bradley EJ, Pitts M, Redman CWE, Calvert E. The experience of long-
term hospital follow-up for women who have suffered early stage
gynecological cancer: a qualitative interview study. Int J Gynecol
Cancer 1999; 9(6): 491–496.
24. Brown L, Payne S, Royle G. Patient initiated follow up of breast
cancer. Psychooncology 2002; 11(4): 346–355.
25. Cox K,Wilson E, Heath W, et al. Preferences for follow-up after
treatment for lung cancer.Cancer Nurs 2006; 29(3): 176–187.
26. Jiwa M, Thompson J, Coleman R, Reed M. Breast cancer follow-up:
could primary care be the right venue? Curr Med Res Opin 2006;
22(4): 625–630.
27. Johansson B, Berglund G, Hoffman K, et al. The role of the general
practitioner in cancer care and the effect of an extended information
routine. Scand J Prim Health Care 2000; 18(3): 143–148.
28. Koinberg IL, Holmberg L, Fridlund B. Breast cancer patients’
satisfaction with a spontaneous system of check-up visits to a
specialist nurse. Scand J Caring Sci 2002; 16(3): 209–215.
29. Koinberg I, Holmberg L, Fridlund B. Satisfaction with routine follow-
up visits to the physician — the needs of patients with breast cancer.
Acta Oncol 2001; 40(4): 454–459.
30. McIlveney C. Evaluation of the nurse led follow up clinic for breast
cancer patients.Middlesbrough: University of Teeside, 2004.
31. Moore S,Wells M, Plant H, et al. Nurse specialist led follow-up in
lung cancer: the experience of developing and delivering a new model
of care. Eur J Oncol Nurs 2006; 10(5): 364–377.
32. Pennery E, Mallet J. A preliminary study of patients’ perceptions of
routine follow-up after treatment for breast cancer. Eur J Oncol Nurs
2000; 4(3): 138–145.
33. Sahay TB, Gray RE, Fitch M.A qualitative study of patient
perspectives on colorectal cancer.Cancer Pract 2000; 8(1): 38–44.
34. Wong DKP, Chow SF. A qualitative study of patient satisfaction with
follow-up cancer care: the case of Hong Kong. Patient Educ Couns
2002; 47(1): 13–21.
35. Wood ML, McWilliam CL. Cancer in remission. Challenge in
collaboration for general practitioners and oncologists.Can Fam
Physician 1996; 42: 899-904; 907–910.
36. Hanselius P.Women operated for breast cancer — their opinion of
follow-up by breast cancer nurse [poster 1628]. Eur J Cancer Suppl
2005; 3(2): 470.
37. Murchie P, Hannaford PC, Nicolson MC, et al. Attending the general
practitioner for routine melanoma follow-up: the practical
experiences of participants in an RCT. In: The Society for Academic
Primary Care 35th Annual Scientific Meeting; 2006 12–14 July 2006,
Keele University, UK.
38. Hughes DC. Breast cancer follow-up; a focus group study to explore
women’s experiences and preferences in relation to type and venue of
follow-up [Abstract]. National Research Register (NRR) (accessed Feb
2007).
39. Thompson J. Breast cancer after care: psycho-social support in general
practice [Abstract].National Research Register (NRR) (accessed Feb
2007).
40. Dixon-Woods M, Bonas S, Booth A, et al. How can systematic reviews
incorporate qualitative research? A critical perspective.Qual Res 2006;
6: 27–44.
41. Mays N, Pope C. Qualitative research in health care: assessing quality
in qualitative research. BMJ 2000; 320(7226): 50–52.
42. Spencer L, Ritchie J, Lewis J, Dillon L, National Centre for Social
Research.Quality in qualitative evaluation: a framework for assessing
research evidence. London: Government Chief Social Researcher’s
Office, 2003.
43. Pope C, Mays N, Popay J. Synthesizing qualitative and quantitative
health evidence: a guide to methods. Maidenhead: McGraw Hill, 2007.
44. Dixon-Woods M,Agarwal S, Young B, et al. Integrative approaches to
qualitative and quantitative evidence. London: Health Development
Agency, 2004.
45. Chlebowski RT, Blackburn GL, Elashoff RE, et al. Dietary fat
reduction in postmenopausal women with primary breast cancer:
Phase III Women’s Intervention Nutrition Study (WINS). J Clin Oncol
2005; 23(16S): 10.
46. Holmes MD, Chen WY, Feskanich D, et al. Physical activity and
survival after breast cancer diagnosis. JAMA 2005; 293(20):
2479–2486.
47. Patel AV, Press MF, Meeske K, et al. Lifetime recreational exercise
activity and risk of breast carcinoma in situ.Cancer 2003; 98(10):
2161–2169.
48. Papagrigoriadis S, Heyman B. Patients’ views on follow up of
colorectal cancer: implications for risk communication and decision
making. Postgrad Med J 2003; 79(933): 403–407.
49. National Institute for Clinical Excellence. Improving outcomes in
colorectal cancers — the manual update. London: National Institute of
Clinical Excellence, 2004.
50. National Institute for Clinical Excellence. Improving outcomes in breast
cancer — the manual update. London: National Institute for Clinical
Excellence, 2002.
51. Grunfeld E, Mant D,Yudkin P, et al. Routine follow up of breast
cancer in primary care: randomised trial. BMJ 1996; 313(7058):
665–669.
52. Holtedahl K, Norum J, Anvik T, Richardsen E. Do cancer patients
benefit from short-term contact with a general practitioner following
cancer treatment? A randomised controlled study. Support Care
Cancer 2005; 13(11): 949–956.
53. Johansson B, Holmberg L, Berglund G, et al. Reduced utilisation of
specialist care among elderly cancer patients: a randomised study of a
primary healthcare intervention. Eur J Cancer 2001; 37(17):
2161–2168.
54. Koinberg IL, Fridlund B, Engholm GB, Holmberg L. Nurse-led
follow-up on demand or by a physician after breast cancer surgery: a
randomised study. Eur J Oncol Nurs 2004; 8(2): 109–117.
